Skip to content
HowShorted

ROCKET PHARMACEUTICALS, INC. short interest in 2024

In 2024, ROCKET PHARMACEUTICALS, INC.'s disclosed short interest ran from 9.15% of shares outstanding on 12 Jan 2024 to 14.18% on 31 Dec 2024, a change of +5.03 percentage points. The year's high was 14.18% on 31 Dec 2024 and its low 9.15% on 12 Jan 2024, averaging 11.40% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.71 days on 13 Sep 2024. Full history: ROCKET PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ROCKET PHARMACEUTICALS, INC. in 2024

2024 in figures

Start of year
9.15% (12 Jan 2024)
End of year
14.18% (31 Dec 2024)
Change
+5.03 pp
High
14.18% (31 Dec 2024)
Low
9.15% (12 Jan 2024)
Average
11.40%
Highest days to cover
19.71 (13 Sep 2024)
SEC filings marked
8

Every report in 2024

ROCKET PHARMACEUTICALS, INC. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20249.15%12.27
31 Jan 20249.37%12.65
15 Feb 202410.20%12.58
29 Feb 202411.05%12.16results (8-K), 10-K filed
15 Mar 202411.36%11.79
28 Mar 202411.67%18.84
15 Apr 202412.21%17.52
30 Apr 202410.91%13.06
15 May 202411.01%19.46results (8-K), 10-Q filed
31 May 202410.37%14.10
14 Jun 202410.20%14.50
28 Jun 20249.26%5.40
15 Jul 202410.62%14.11
31 Jul 202411.60%15.10
15 Aug 202412.01%13.15results (8-K), 10-Q filed
30 Aug 202412.01%16.16
13 Sep 202412.38%19.71
30 Sep 202412.53%8.73
15 Oct 202412.66%11.84
31 Oct 202413.08%19.14
15 Nov 202412.17%12.9010-Q filed, results (8-K)
29 Nov 202411.39%9.05
13 Dec 202412.26%7.95
31 Dec 202414.18%7.46

See also: ROCKET PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.